Search Results - "Gkioka, Annita"

Vestibular-guided visual search by Smith, Laura, Gkioka, Annita, Wilkinson, David

“…The amnesic symptoms that accompany vestibular dysfunction point to a functional relationship between the vestibular and visual memory systems. However, little…”
Get full text

Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group by Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Delimpasi, Sosana, Spanoudakis, Emmanouil, Labropoulou, Vasiliki, Ntanasis‐Stathopoulos, Ioannis, Gkioka, Annita‐Ioanna, Giannakoulas, Nikos, Kanellias, Nikolaos, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michalis, Eyrydiki, Papathanasiou, Maria, Kotsopoulou, Maria, Sioni, Anastasia, Triantafyllou, Theodora, Daiou, Aikaterini, Papadatou, Mavra, Kyrtsonis, Marie‐Christine, Pouli, Anastasia, Kostopoulos, Ioannis, Verrou, Evgenia, Dimopoulos, Meletios‐Athanasios, Terpos, Evangelos

“…We evaluated the efficacy and prognostic impact of bortezomib‐lenalidomide triplet (VRd) or daratumumab‐based quadruplets (DBQ) versus previous anti‐myeloma…”
Get full text

Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group by Katodritou, Eirini, Dalampira, Dimitra, Delimpasi, Sosana, Ntanasis‐Stathopoulos, Ioannis, Karaolidou, Fryni, Gkioka, Annita‐Ioanna, Labropoulou, Vasiliki, Spanoudakis, Emmanouil, Triantafyllou, Theodora, Kotsopoulou, Maria, Michalis, Eyrydiki, Vadikolia, Chrysanthi, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michael, Michael, Daiou, Aikaterini, Pentidou, Aikaterini, Kostopoulos, Ioannis, Palaska, Vasiliki, Gavriatopoulou, Maria, Kyrtsonis, Marie‐Christine, Verrou, Evgenia, Kastritis, Efstathios, Dimopoulos, Meletios‐Athanasios, Terpos, Evangelos

“…Central nervous system (CNS) involvement is a rare and aggressive complication of multiple myeloma (MM). We identified 54/4352 MM patients (1.2%), who…”
Get full text

Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group by Katodritou, Eirini, Kastritis, Efstathios, Gatt, Moshe, Cohen, Yael C., Avivi, Irit, Pouli, Anastasia, Lalayianni, Chrysavgi, Lavi, Noa, Delimpasis, Sosana, Kyrtsonis, Marie‐Christine, Michael, Michalis, Suriu, Celia, Miri, Zektser, Tzafarti, Katrin, Vadikoliou, Chrysanthi, Maltezas, Dimitris, Zikos, Panagiotis, Ganzel, Chezi, Vaxman, Yuliana, Aviv, Ariel, Christoforidou, Anna, Gavriatopoulou, Maria, Shaulov, Adir, Verrou, Evgenia, Papanota, Aristea‐Maria, Fakinos, Gabriel, Gkioka, Annita‐Ioanna, Palaska, Vasiliki, Triantafyllou, Theodora, Konstantinidou, Pavlina, Anagnostopoulos, Achilles, Terpos, Evangelos, Dimopoulos, Meletios A.

“…We investigated incidence, characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) treated mainly with novel therapies. Based on…”
Get full text

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS by Gkioka, Annita‐Ioanna, Gkiokas, Alexandros, Alexandropoulos, Alexandros, Papadatou, Mavra, Koudouna, Aspasia, Bartzi, Vasilliki, Tryfou, Thomai‐Marina, Kyrtsonis, Marie Christine

Get full text

Serum-Soluble CD163 Levels as a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma Treated with Chemoimmunotherapy by Koudouna, Aspasia, Gkioka, Annita Ioanna, Gkiokas, Alexandros, Tryfou, Thomai M, Papadatou, Mavra, Alexandropoulos, Alexandros, Bartzi, Vassiliki, Kafasi, Nikolitsa, Kyrtsonis, Marie-Christine

“…The majority of patients with Diffuse Large B-cell Lymphoma (DLBCL) will respond to first-line treatment and be cured. However, the disease is heterogeneous,…”
Get full text

Circulating miR-16 and miR-21 Levels in Multiple Myeloma: Prognostic Significance of Survival and Response to Lenalidomide Treatment by Gkioka, Annita-Ioanna, Tsota, Maria, Koudouna, Aspasia, Gkiokas, Alexandros, Mitropoulou, Christina-Aggeliki, Palaiokrassa, Aikaterini, Alexandropoulos, Alexandros, Papadatou-Gigante, Mavra, Bartzi, Vasiliki, Tryfou, Thomais-Marina, Sfikakis, Petros P, Dedoussis, George V, Kyrtsonis, Marie-Christine

“…MicroRNAs (miRNAs), particularly miR-16 and miR-21, play a crucial role in multiple myeloma (MM) pathogenesis by regulating gene expression. This study…”
Get full text

The Modulation of Visual Spatial Memory by Galvanic Vestibular Stimulation by Gkioka, Annita

“…It is now widely accepted that the vestibular system not only affects autonomic motor function but cognitive function too, most notably visuospatial learning…”
Get full text

Soluble CD163; A Possible New Biomarker in Multiple Myeloma by Gkioka, Annita Ioanna, Gkiokas, Alexandros, Alexandropoulos, Alexandros, Papadatou, Mavra, Koudouna, Aspasia, Vasiliki, Bartzi, Tryfou, Thomai-Marina, Kafasi, Nikolitsa, Kyrtsonis, Marie-Christine

“…INTRODUCTION Tumor associated macrophages (TAM) constitute a major part of the bone marrow microenvironment and play a pivotal role in growth of various…”
Get full text

P-168 Serum BLYS and Soluble (sBCMA) Levels in Multiple Myeloma (MM) Patients by Gkioka, Annita-Ioanna, Alexandropoulos, Alexandros, Gkiokas, Alexandros, Papadatou-Gigante, Mavra, Koudouna, Aspasia, Tryfou, Thommais-Marina, Bartzi, Vasiliki, Kyrtsonis, Marie-Christine

Get full text

Serum Soluble Syndecan-1 (ssCD138) Can Contribute to the Discrimination of Lenalidomide Resistant Multiple Myeloma (MM) Patients by Gkioka, Annita Ioanna, Koudouna, Aspasia, Bartzi, Vasiliki, Dimou, Maria, Iliakis, Theodoros, Bitsani, Aikaterini, Pardalis, Vasileios, Panayiotidis, Panayiotis, Kyrtsonis, Marie-Christine

“…Background Lenalidomide resistance is one of the main emerging therapeutical concerns in MM. SsCD138 levels were shown of prognostic significance in MM at…”
Get full text

P-174: Validation of Mayo Clinic 2018 and IMWG 2020 prognostic risk score for smoldering multiple myeloma (SMM), real world data; single center experience by Gkiokas, Alexandros, Gkioka, Annita Ioanna, Papadatou, Mavra, Alexandropoulos, Alexandros, Bartzi, Vasiliki, Kyrtsonis, Marie-Christine

Get full text

P-192 Increased serum CRBN levels are associated with improved survival in MM patients by Gkioka, Annita Ioanna, Gkiokas, Alexandros, Papadatou-Gigante, Mavra, Alexandropoulos, Alexandros, Koudouna, Aspasia, Bartzi, Vasilliki, Kyrtsonis, Marie-Christine

Get full text

P-169 Tumor Associated Macrophages’ cytokines; CD163, CCL4 and CCL2, as Possible New Biomarkers for Overall Survival and Transformation in Smoldering Multiple Myeloma by Gkiokas, Alexandros, Gkioka, Annita-Ioanna, Papadatou-Gigante, Mavra, Alexandropoulos, Alexandros, Bartzi, Vasiliki, Kafasi, Nikolitsa, Kyrtsonis, Marie-Christine, Tryfou, Thommais-Marina, Koudouna, Aspasia

Get full text

Update Analysis of Central Nervous System Multiple Myeloma Prognosis and Survival: A Real-World Multi-Institutional Study of the Greek Myeloma Study Group by Katodritou, Eirini, Dalampira, Dimitra, Delimpasi, Sosana, Ntanasis-Stathopoulos, Ioannis, Karaolidou, Frini, Gkioka, Annita Ioanna, Labropoulou, Vasiliki, Spanoudakis, Emmanouil, Triantafyllou, Theodora, Kotsopoulou, Maria, Michalis, Eyrydiki, Vadikolia, Chrysanthi, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michael, Michael, Daiou, Aikaterini, Pentidou, Aikaterini, Kostopoulos, Ioannis V, Palaska, Vasiliki, Gavriatopoulou, Maria, Kyrtsonis, Marie-Christine, Verrou, Evgenia, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos

“…Central Nervous System Multiple Myeloma (CNS-MM) is a rare but aggressive complication of MM, and its treatment remains an unmet clinical need. Herein we…”
Get full text

Improved Survival of Patients with Primary Plasma Cell Leukemia with VRD or Daratumumab-Based Quadruplets: A Multicenter Study By the Greek Myeloma Study Group by Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Delimpasi, Sosana, Spanoudakis, Emmanouil, Labropoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Gkioka, Annita Ioanna, Giannakoulas, Nikolaos, Kanellias, Nikolaos, Sevastoudi, Aggeliki, Michali, Evridiki, Papathanasiou, Maria, Kotsopoulou, Maria, Sioni, Anastasia, Triantafyllou, Theodora, Papadatou, Mavra, Kostopoulos, Ioannis V, Verrou, Evgenia, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos

Get full text

The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development by Crotta, Stefania, Gkioka, Annita, Male, Victoria, Duarte, João H, Davidson, Sophia, Nisoli, Ilaria, Brady, Hugh J M, Wack, Andreas

“…NK cells contribute to antitumor and antiviral immunosurveillance. Their development in the bone marrow (BM) requires the transcription factor E4BP4/NFIL3, but…”
Get full text

P-085: Updated outcomes on Lenalidomide (Len) refractory MM patients by Gkioka, Annita Ioanna, Papadatou, Mavra, Gkiokas, Alexandros, Koudouna, Aspasia, Bartzi, Vasiliki, Bitsani, Aikaterini, Iliakis, Theodoros, Dimou, Maria, Pardalis, Vasileios, Panayiotidis, Panayiotis, Kyrtsonis, Marie-Christine

“…Lenalidomide refractoriness constitutes an adverse factor of survival in MM as Lenalidomide relapsing/resistant patients were reported to respond difficultly…”
Get full text

Uninvolved Immunoglobulin Suppression Determined By “Hevylite” ASSAY. Strongly Predicts Evolution of Smoldering Myeloma (SMM) to Symptomatic Multiple Myeloma (MM) by Papaioannou, Paraskevi, Gkioka, Annita Ioanna, Tsalimalma, Kallirroi, Koudouna, Aspasia, Kopsaftopoulou, Anastasia, Chamoulkou, Konstantina, Grafakos, Ioannis, Bitsani, Aikaterini, Iliakis, Theodoros, Dimou, Maria, Kafassi, Nikolitsa, Sfikakis, Petros, Panayiotidis, Panayiotis, Kyrtsonis, Marie-Christine

“…SMM may have an indolent course and remain stable for years; however, some patients evolve to MM requiring treatment within two years or less. To timely…”
Get full text

Increased SERUM VON Willebrand Levels in Chronic Lymphocytic Leukemia (CLL) Patients Are Related to a Shorter Time to Treatment by Tryfou, Thommais, Papaioannou, Paraskevi, Repousis, Panagiotis, Gkioka, Annita Ioanna, Sachanas, Sotirios, Bitsani, Aikaterini, Dimou, Maria, Maltezas, Dimitrios, Koudouna, Aspasia, Kopsaftopoulou, Anastasia, Chamoulkou, Konstantina, Grafakos, Ioannis, Kokori, Styliani, Tsantes, Argyrios, Pangalis, Gerasimos, Panayiotidis, Panayiotis, Kyrtsonis, Marie-Christine

“…CLL is a frequent and usually indolent disease that require only follow-up in about 2/3 of patients while the rest 1/3 of patients are symptomatic, have a…”
Get full text